A classmate offers a ‘concentration pill’ before an exam. Is it a study aid? In a joint release dated September 28, 2026, Korea’s Ministry of Food and Drug Safety (식품의약품안전처, MFDS), Ministry of Education and Ministry of Gender Equality and Family emphasized that there is “no medicine that makes you study well.” Methylphenidate is a prescription medicine regulated as a medical narcotic under Korean law and used to treat conditions such as ADHD. Its proper medical use must not be conflated with taking somebody else’s prescription for grades.
Match the situation to the safe next step
| Situation | Avoid | Instead |
|---|---|---|
| Someone offers you their remaining tablets | Sharing or taking a prescription issued to another person | Do not take it; consult a doctor if you are concerned about your symptoms |
| A social-media account advertises a ‘study drug’ | Buying or taking it without a prescription | Do not respond to the seller; seek legitimate medical advice if needed |
| You already take medicine prescribed for ADHD | Stopping it or changing a dose because of a general article | Discuss use, symptoms or possible adverse effects with your own prescriber |
The MFDS release warns that use without the relevant medical condition may cause headaches and anxiety, and in severe cases hallucinations. This is not a claim that every user will experience those effects or an individualized risk estimate. The release also says buying without a prescription via social media, or taking pills obtained from another person, may be punishable under applicable law. Whether a particular case breaches the law cannot be determined here.
If you receive an offer or already have a prescription
- Check whose prescription it is. Do not take medicine issued to someone else or share yours.
- Ask for diagnosis, not a performance shortcut. Trouble concentrating by itself does not establish ADHD. A doctor should assess symptoms and any need for treatment.
- If the medicine is yours, ask your clinician. This article is not advice on doses, discontinuation or switching. Do not change your treatment yourself because of it.
- If there is a substance-use problem, seek support. The official release lists Korea’s anonymous, confidential 24-hour drug-use counselling line 1342 and the KakaoTalk channel ‘1342용기한걸음 마약류 상담센터’. Individual treatment decisions belong with a clinician.
The release’s 1,733 figure refers to online illegal-sale or brokering posts involving methylphenidate identified for blocking by August 2026. It is not a count of patients, users or the probability of harm. The practical distinction is between legitimate prescribed treatment and taking or purchasing unprescribed pills. The cover is a labeled AI-generated conceptual image, not a photograph of actual medical care; the explanatory cards were created separately.
A shorter Korean guide is also available on the Life Mokcha Naver blog. For personal treatment, rely on your own medical team.
About the Author
The Life Mokcha editorial team (목차지기) separates evidence about prescribed treatment from the risks of unprescribed use.
References
- MFDS and partner ministries, methylphenidate misuse-prevention release (September 28, 2026; Korean)
- Official press-release PDF (treatment purpose, adverse effects, unprescribed purchase and 1342; checked September 30, 2026; Korean)
